Humana priced its 2027 Medicare Advantage plans for margin as costs rise 8% to 9%
Humana told investors on Friday that profit margin came first in its 2027 Medicare Advantage bids, with medical costs expected to rise faster than this year and drug costs faster still.

Humana expects its core medical costs to grow 8% to 9% in 2027, up from the 7% to 8% it planned for this year, and it priced its 2027 Medicare Advantage plans with margin as the first priority, chief financial officer Celeste Mellet said on the company's third-quarter earnings call on Friday. The insurer also raised its 2026 adjusted earnings guidance to at least $9.50 a share from at least $9.00, according to the results it filed1 with the Securities and Exchange Commission (SEC).
Medicare Advantage insurers set each year's premiums, benefits and out-of-pocket limits in bids filed with the federal government the previous June, so the call was a look at the thinking behind plans that people over 65 are choosing right now. Open enrollment for 2027 coverage runs through December 7, according to Medicare5. When an insurer prices for margin against higher expected costs, there is less room in the bid for extra benefits or lower premiums. Humana did not detail benefit changes on the call. Chief executive Jim Rechtin described the 2027 lineup as protecting the benefits seniors say matter most.
What the quarter showed
Revenue reached $41.2 billion in the third quarter, up from $32.6 billion a year earlier, according to the SEC filing. Humana reported earnings of $1.33 a share on a GAAP basis and an adjusted loss of $0.70 a share. The insurance segment spent 93.7% of premiums on medical care, better than the "slightly above 94%" the company had guided to. Analysts had expected 94.39%, Reuters reported4.
Costs this year are running at the lower end of the 7% to 8% range the company had expected, Mellet said. In prepared remarks2 filed alongside the results, Humana said it expects the insurance segment's benefit ratio to rise to just above 95.5% in the fourth quarter, and that its adjusted earnings for 2026 will still be below 2025 because of a Star Ratings headwind for bonus year 2026, net of steps taken to offset it.
Humana added about 1,208,000 individual Medicare Advantage members in the first nine months of the year, a 23% increase, and said that growth is tracking its full-year expectation of about 25%, according to the prepared remarks.
What was said about 2027
Mellet said on the call, in the transcript published by The Motley Fool3, that "our #1 priority in AEP was to price for margin," referring to the annual enrollment period. She said the company significantly improved its product position for 2027.
The sharpest increase is in drug costs. Humana expects its Part D costs to rise 14% to 15% next year, driven by what Mellet called the health technology pipeline, meaning new high-cost drugs. She said that trend was priced into the bids for both Medicare Advantage plans with drug coverage and stand-alone Part D plans.
Rechtin said the company still expects its membership to be up in 2027, but that it is too early to put a number on it and that growth will not look like last year's. Mellet pointed to the number of plan exits across most of the major insurers as part of the backdrop.
The company's stated goal is a pre-tax margin of at least 3% on individual Medicare Advantage in 2028, and the prepared remarks say the approach to 2027 bids should drive meaningful progress toward it. Humana also said its Medicare Advantage Star Ratings for bonus year 2028, which feed into quality bonus payments for 2028, are industry leading.
What comes next
Open enrollment for 2027 Medicare Advantage and Part D plans ends December 7, and coverage under any new plan starts January 1, according to Medicare. Humana said it would not estimate 2027 membership until the enrollment period is further along. The figures to watch are the insurer's fourth-quarter benefit ratio, which it expects to be just above 95.5%, and whether the 8% to 9% medical cost assumption and the 14% to 15% Part D assumption hold once 2027 claims start arriving.



